Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, December 05, 2024
Cambrex, announced that it has signed an agreement with Eli Lilly and Company (Lilly) to deliver accelerated access to clinical development capabilities for Lilly's biotech collaborators.
read more
Wednesday, December 04, 2024
Merck announced that the National Medical Products Administration (NMPA) in China has approved WELIREG® (belzutifan), for the treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated renal cell carcinoma (...
read more
Wednesday, December 04, 2024
Univar Solutions LLC announced its selection as the sole channel partner for SD Head USA for the pharmaceutical industry across North America.
read more
Wednesday, December 04, 2024
N4 Pharma Plc announced a new lead program N4 101. This orally-delivered inflammation inhibitor for Irritable Bowel Disease (IBD) uses Nuvec®, the company’s novel silica non-viral, non-lipid nanoparticle delivery system, to overcome the challenges ...
read more
Tuesday, December 03, 2024
Sapio Sciences announced that evitria, a provider of antibody expression services, has selected Sapio’s Electronic Lab Notebook (ELN) and Sapio Report Builder to enhance its sample tracking, data capture, and reporting capabilities.
read more
Tuesday, December 03, 2024
Avania, a MedTech advisory and clinical development partner, announced the appointment of operational strategy expert Charlene Dark as chief operating officer (COO).
read more
Tuesday, December 03, 2024
BioDuro-Sundia, a contract research, development, and manufacturing organization, announced the appointment of Alan Findlater as Chief Commercial Officer.
read more
Tuesday, December 03, 2024
KBI Biopharma, Inc. announced a manufacturing contract with Alanis Therapeutics, Inc. (ATI) for the development of an innovative pre-clinical therapeutic antibody to treat myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) blood cancers...
read more
Tuesday, November 26, 2024
VectorBuilder, a provider of end-to-end gene delivery services, and Sartorius, a provider of life science research service for the biopharmaceutical industry, announced a strategic cooperation agreement.
read more
Tuesday, November 26, 2024
Hovione, announced completion of significant expansions in Europe and the USA. The investments at its East Windsor, New Jersey, and Ringaskiddy, Cork, facilities will significantly increase Hovione's global spray drying capacity and enhance the sites...
read more
Tuesday, November 26, 2024
Adragos Pharma has acquired Baccinex, a Swiss-based provider of aseptic fill-finish manufacturing services. This acquisition significantly enhances Adragos’ sterile manufacturing capabilities and marks a pivotal step in the expansion of its global ...
read more
Thursday, November 21, 2024
Alloy Therapeutics Inc. announced a strategic collaboration and license agreement with Takeda Pharmaceutical Company to develop Takeda’s proprietary induced pluripotent stem cell (iPSC) derived CAR-T cell platform (iCAR-T) and iPSC-derived CAR-NK ...
read more
Thursday, November 21, 2024
Vetter has announced the appointment of three senior leaders to take on the role of managing directors alongside Thomas Otto and Peter Soelkner.
read more
Thursday, November 21, 2024
GBI Biomanufacturing (GBI) announced the expansion of its Drug Product (DP) services, to include automated sterile fill and finish capabilities. GBI has the ability to support clients from clinical trials to commercial launch, for both Drug Substance...
read more
Thursday, November 21, 2024
NorthStar Medical Radioisotopes announced the signing of a strategic Master Supply Agreement with Cellectar Biosciences, Inc. under which Cellectar will acquire and integrate NorthStar’s n.c.a. Ac-225 into Cellectar’s proprietary Phospholipid Ethers ...
read more